Every Form 4 that Telix Pharmaceuticals Limited (TLX) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow TLX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full TLX filings page.
Telix Pharmaceuticals Ltd (TLX) reported that its Group Chief Financial Officer, Darren Charlton Smith, purchased 2,071 Ordinary Shares on September 7, 2026. The shares were acquired at 9.656 per share in Australian Dollars under the Employee Share Purchase Plan section of the company’s Equity Incentive Plan, bringing his direct holdings to 13,992 shares.
Telix Pharmaceuticals Ltd MD & Group CEO Dr. Christian Behrenbruch, through Elk River Holdings Pty Ltd, made two open-market purchases of Ordinary Shares. On April 28 and 29, he indirectly bought a combined 67,935 shares at average prices around $14.48 and $14.87 per share, reported in Australian Dollars. After these transactions, his indirect holdings rose to 20,742,935 Ordinary Shares. The filing notes that the reported prices are volume-weighted averages for multiple trades within specified price ranges.
Telix Pharmaceuticals Group Chief Financial Officer Darren Charlton Smith exercised previously granted share rights into ordinary shares. On March 29, 2026, he converted 1,111 share rights into 1,111 ordinary shares at an exercise price of $0.00 per share. These share rights were granted on January 1, 2025 and became vested and exercisable on March 5, 2026. Following the transaction, he directly holds 11,921 ordinary shares of Telix Pharmaceuticals Ltd, and the exercised share rights position has been fully used with no remaining derivative balance reported. No open-market sale occurred in this filing; it reflects a routine compensation-related option exercise that increases his direct share ownership.